Dr. Carlos Robles, MD

Dr. Robles practices at Saint Francis Medical Center in Cape Girardeau, Missouri, part of Saint Francis Healthcare System.

Dr. Robles' NPI, 1992755441, was assigned on May 12, 2006. Dr. Robles graduated from Universidad Anahuac School of Medicine in 1993. Dr. Robles holds Missouri license 2007035472.

Dr. Robles' primary practice is Saint Francis Medical Center, at 211 St Francis Dr, Cape Girardeau, MO 63703 in Cape Girardeau County. The practice phone is (573) 331-3000.

Dr. Robles' primary practice is Saint Francis Medical Center in Cape Girardeau, Missouri, part of Saint Francis Healthcare System. Dr. Robles is also affiliated with Mercy Hospital Southeast. The medical group on file is Saint Francis Medical Center. Dmand AI also links Dr. Robles to 1 more hospital, 1 hospice and 1 medical group, each named with a free account. Dr. Robles' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Robles practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Robles' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Robles is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Robles' licenses on file in 2 states: Missouri and Florida.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphedema, lymphoma and multiple myeloma among the conditions Dr. Robles treats.

CMS data shows 2,406 Medicare services from Dr. Robles across 7 procedure codes in 2024, for 464 Medicare patients. Medicare paid $105,628 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 464 Medicare patients who saw Dr. Robles in 2024. The largest group is 75 to 84, with 204 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Robles' median patient age at 74, with 56% women.

In 2024, Dr. Robles wrote 1,398 Medicare Part D claims for 213 patients. 83% of them were for generic drugs. CMS names the drug for 1,173 of them, across 33 drugs with 11 or more claims each, at $1,822,103 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 67 out of 100 for Dr. Robles for performance year 2024, reported through an alternative payment model (APM). Dr. Robles accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Robles. Dr. Robles' most frequent co-authors are Charles David Blanke, MD, Tomislav Dragovich, MD, PhD and Heinz-Josef Lenz, MD.

CMS Open Payments shows 77 general payments to Dr. Robles from 25 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 94% of the total. AstraZeneca Pharmaceuticals LP paid the most, $431.

Dr. Robles graduated from Universidad Anahuac School of Medicine in 1993.

Dr. Robles is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.